Champions Oncology's top three insider shareholders as of March 23, 2026 are Joel Ackerman (Director, 1.06Mn shares), Ronnie Morris (Ceo, 858.88K shares), David Sidransky (Director, 767.04K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Joel Ackerman | 1,056,539 | 0 | 30 Oct, 2025 | |
| Joel Ackerman | 1,056,539 | 0 | 30 Oct, 2025 | |
| Ronnie Morris | Ceo | 858,878 | 0 | 21 Mar, 2023 |
| David Sidransky | 767,043 | 0 | 12 Oct, 2022 | |
| Daniel Newman Mendelson | 198,625 | 0 | 16 Jan, 2024 | |
| Scott R Tobin | 30,000 | 0 | 12 Oct, 2022 | |
| Philip P. Breitfeld | 5,717 | 0 | 02 Apr, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Nov, 2025 | Daniel Newman Mendelson | Option to purchase Common Stock | A | 13,790 | $6.80 | 13,790 | D | A |
| 05 Nov, 2025 | Joel Ackerman | Option to purchase Common Stock | A | 21,216 | $6.80 | 21,216 | D | A |
| 05 Nov, 2025 | Joel Ackerman | Option to purchase Common Stock | A | 21,216 | $6.80 | 21,216 | D | A |
| 05 Nov, 2025 | Scott R Tobin | Option to purchase Common Stock | A | 25,460 | $6.80 | 25,460 | D | A |
| 05 Nov, 2025 | David Sidransky | Option to purchase Common Stock | A | 21,216 | $6.80 | 21,216 | D | A |
| 05 Nov, 2025 | Philip P. Breitfeld | Option to purchase Common Stock | A | 13,790 | $6.80 | 13,790 | D | A |
| 30 Oct, 2025 | Joel Ackerman | Common Stock | A | 94,405 | $2.10 | 1,056,539 | D | M |
| 30 Oct, 2025 | Joel Ackerman | Common Stock | A | 94,405 | $2.10 | 1,056,539 | D | M |
| 30 Oct, 2025 | Joel Ackerman | Option to purchase Common Stock | D | 94,405 | $2.10 | 0 | D | M |
| 30 Oct, 2025 | Joel Ackerman | Option to purchase Common Stock | D | 94,405 | $2.10 | 0 | D | M |
| 25 Mar, 2025 | Philip P. Breitfeld | Common Stock | D | 4,150 | $0.00 | 5,717 | D | J |
| 12 Nov, 2024 | Joel Ackerman | Option to purchase Common Stock | A | 43,190 | $4.64 | 43,190 | D | A |
| 12 Nov, 2024 | Scott R Tobin | Option to purchase Common Stock | A | 34,550 | $4.64 | 34,550 | D | A |
| 12 Nov, 2024 | David Sidransky | Option to purchase Common Stock | A | 21,880 | $4.64 | 21,880 | D | A |
| 12 Nov, 2024 | Philip P. Breitfeld | Option to purchase Common Stock | A | 18,715 | $4.64 | 18,715 | D | A |
| 12 Nov, 2024 | Joel Ackerman | Option to purchase Common Stock | A | 43,190 | $4.64 | 43,190 | D | A |
| 12 Nov, 2024 | Daniel Newman Mendelson | Option to purchase Common Stock | A | 21,590 | $4.64 | 21,590 | D | A |
| 31 Oct, 2024 | Joel Ackerman | Common Stock | A | 88,470 | $2.10 | 945,467 | D | M |
| 31 Oct, 2024 | Joel Ackerman | Common Stock | A | 88,470 | $2.10 | 945,467 | D | M |
| 31 Oct, 2024 | Joel Ackerman | Common Stock | A | 16,667 | $5.43 | 962,134 | D | M |